News | March 31, 2026
Roche launches groundbreaking multiplex test to boost blood safety
The new assay consolidates screening for four major viral threats into a single workflow
The new assay consolidates screening for four major viral threats into a single workflow
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
Pfizer recommends that shareholders do not tender their shares in response to Tutanota’s offer
Subscribe To Our Newsletter & Stay Updated
